PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF(WT) melanoma cells

BRAF(V600E/K) is a frequent mutationally active tumor-specific kinase in melanomas that is currently targeted for therapy by the specific inhibitor PLX4032. Our studies with melanoma tumor cells that are BRAF(V600E/K) and BRAF(WT) showed that, paradoxically, while PLX4032 inhibited ERK1/2 in the hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Halaban, Ruth, Zhang, Wengeng, Bacchiocchi, Antonella, Cheng, Elaine, Parisi, Fabio, Ariyan, Stephan, Krauthammer, Michael, McCusker, James P, Kluger, Yuval, Sznol, Mario
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848976/
https://www.ncbi.nlm.nih.gov/pubmed/20149136
http://dx.doi.org/10.1111/j.1755-148X.2010.00685.x

Ejemplares similares

Ejemplares similares